Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
71.18
-3.63 (-4.85%)
Mar 7, 2025, 4:00 PM EST - Market closed

Vaxcyte Statistics

Total Valuation

Vaxcyte has a market cap or net worth of $9.17 billion. The enterprise value is $7.49 billion.

Market Cap 9.17B
Enterprise Value 7.49B

Important Dates

The last earnings date was Tuesday, February 25, 2025, after market close.

Earnings Date Feb 25, 2025
Ex-Dividend Date n/a

Share Statistics

Vaxcyte has 128.76 million shares outstanding. The number of shares has increased by 25.57% in one year.

Current Share Class 128.76M
Shares Outstanding 128.76M
Shares Change (YoY) +25.57%
Shares Change (QoQ) +9.30%
Owned by Insiders (%) 0.70%
Owned by Institutions (%) 103.96%
Float 119.17M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.69
P/TBV Ratio 2.77
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.75, with a Debt / Equity ratio of 0.02.

Current Ratio 12.75
Quick Ratio 12.61
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -20.41% and return on invested capital (ROIC) is -15.32%.

Return on Equity (ROE) -20.41%
Return on Assets (ROA) -14.47%
Return on Invested Capital (ROIC) -15.32%
Return on Capital Employed (ROCE) -16.89%
Revenue Per Employee n/a
Profits Per Employee -$1.12M
Employee Count 414
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -0.03% in the last 52 weeks. The beta is 1.02, so Vaxcyte's price volatility has been similar to the market average.

Beta (5Y) 1.02
52-Week Price Change -0.03%
50-Day Moving Average 83.48
200-Day Moving Average 89.13
Relative Strength Index (RSI) 33.42
Average Volume (20 Days) 1,186,423

Short Selling Information

The latest short interest is 13.33 million, so 10.36% of the outstanding shares have been sold short.

Short Interest 13.33M
Short Previous Month 13.53M
Short % of Shares Out 10.36%
Short % of Float 11.19%
Short Ratio (days to cover) 11.45

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -569.55M
Pretax Income -497.19M
Net Income -463.93M
EBITDA -562.54M
EBIT -569.55M
Earnings Per Share (EPS) -$3.80
Full Income Statement

Balance Sheet

The company has $1.75 billion in cash and $71.11 million in debt, giving a net cash position of $1.68 billion or $13.02 per share.

Cash & Cash Equivalents 1.75B
Total Debt 71.11M
Net Cash 1.68B
Net Cash Per Share $13.02
Equity (Book Value) 3.31B
Book Value Per Share 26.47
Working Capital 1.65B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$452.63 million and capital expenditures -$119.16 million, giving a free cash flow of -$571.79 million.

Operating Cash Flow -452.63M
Capital Expenditures -119.16M
Free Cash Flow -571.79M
FCF Per Share -$4.44
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Vaxcyte does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -25.57%
Shareholder Yield -25.57%
Earnings Yield -5.06%
FCF Yield -6.24%
Dividend Details

Analyst Forecast

The average price target for Vaxcyte is $147.50, which is 107.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target $147.50
Price Target Difference 107.22%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2